When is a 2L/4L vessel volumetric dissolution test required?
Solutions for human-specific formulations and animal medications.
I. Introduction and Legal Basis
In in vitro dissolution testing of routine human oral solid preparations (tablets, capsules), the standard configuration in major pharmacopoeias of various countries—including the United States Pharmacopeia (USP <711>), the European Pharmacopoeia (EP <2.9.3>), the Japanese Pharmacopoeia (JP <15>), and the Chinese Pharmacopoeia (ChP 0931)—generally uses a standard 1,000 mL (1 L) hemispherical glass with 500 to 900 mL of dissolution medium.
However, when dealing with long-acting/high-dose formulations for human use and veterinary pharmaceuticals, conventional 1L dissolution vessels face insurmountable physical and chemical bottlenecks:
Saturated solubility limitation: It is extremely difficult to maintain the sink condition required by the pharmacopoeia, which can easily lead to the premature appearance of the dissolution plateau effect.
Insufficient physical space: Large long-acting pills or large-area transdermal patches cannot be released naturally in a limited space, and the edges of the patches may hit the walls or curl up.
Boundary flow field interference and shear dead zone: Large solids occupy the bottom space of the cup, which seriously disrupts the symmetrical flow field below the agitator and induces non-physiological stagnation zones (dead zones).
To address the aforementioned bottlenecks, international pharmacopoeias and regulatory review bodies have established clear technical guidelines:
■ USP <711> (General Rules for Dissolution): It clearly states that, unless otherwise specified in individual treatises, standard apparatus shall be used in principle; if otherwise specified in individual treatises or if the methodologically justified, dissolution cups and stirring elements of different capacities (e.g., 2L or 4L) and corresponding geometric dimensions may be used.
■ USP <1092> (The Dissolution Procedure: Development and Validation): The chapter on "Media Volume and Drainage Conditions" emphasizes that maintaining drainage conditions (drug concentration in the media not exceeding 10% to 20% of its saturation solubility Cs, i.e., Cs >= 3 to 10 times the final concentration C_final) is crucial to ensuring that in vitro release dynamics reflect the true prescription characteristics. When the addition of surfactants (such as SLS, Tween) may inhibit spontaneous disintegration of the formulation or alter the micromicelle mechanism, increasing the media volume to 2,000 mL or even 4,000 mL is a fully regulatory-approved preferred alternative strategy.
■ US FDA/CDER (Center for Human Drug Evaluation): For large-area transdermal patches (such as Lidocaine Patch) or special long-acting microsphere injections, clear guidelines have been issued that 2L/4L large volume cups or USP Apparatus 5 (Paddle-over-Disk) expansion discs can be used for in vitro release evaluation.
■ US FDA/CVM (Center for Animal Medicine) and VICH GL39 / GL40: For high-dose long-acting pills (Bolus) or implants specifically for ruminants and large livestock, conventional 1L dissolution cannot provide an environment that conforms to the physiological flow field. They have clearly approved and recommended the use of 2L or 4L proven large-volume dissolution systems, emphasizing the principle of geometrical scaling and hydrodynamic equivalence of the mechanical device.
II. Core Application Scenarios of 2L and 4L Large-Volume Systems (Human Preparations vs. Animal Drugs)
Human Special Formulations
High-Dose Poorly Soluble Drugs (High-Dose BCS Class II & IV APIs): Representative drugs include high-dose antiviral drugs, antifungal drugs, or antitumor targeted drugs (single doses of 500 mg to over 1,000 mg with extremely low water solubility). In a 900 mL medium, even with the legally mandated maximum amount of surfactant added, thermodynamic saturation is rapidly achieved, causing a sharp drop in diffusion drive and failing to accurately represent batch-to-batch prescription release differences. Switching to a 2L or 4L system provides sufficient dilution volume, maintains sink conditions under physiologically compatible conditions with low or no surfactant, and imparts excellent prescription-dispersing power to the dissolution curve.
Long-acting microspheres and in-situ gels: Representative formulations include long-acting microspheres or implantable release agents such as leuprolide acetate, risperidone, and octreotide. Their in vitro release testing cycles often last from several weeks to several months. In a 1L cup, microspheres tend to settle and easily condense at the bottom center, even adhering and agglomerating. Furthermore, frequent multi-point sampling in small volumes can result in a drastic relative volume loss rate. Using a 2L/4L medium ensures that the microspheres are fully dispersed in a uniform low-shear flow field and significantly reduces the impact of sampling on overall volume balance.
Large Transdermal Patches (USP Apparatus 5): Representative dosage forms include 5% lidocaine patches (often with a single patch area of 140 cm²) or large fentanyl patches. The standard 1L cup has a base diameter of only about 100 mm, which is insufficient to hold the paddle-over-disk required to secure large patches, causing the patch edges to curl upwards or rub against the cup wall. Upgrading to 2L (inner diameter approximately 120~125 mm) or 4L (inner diameter approximately 145~150 mm) systems allows the entire patch to be flatly secured on a specialized paddle, ensuring 100% uniform contact of the active ingredient release surface with the medium.
Veterinary Pharmaceuticals
Veterinary Large Bolus (Veterinary Large Bolus): Representative products include long-acting sustained-release pills for cattle and sheep such as abendazole, ivermectin, triclabendazole, and monensin. A single dose often weighs 5 to over 40 grams, with a length of 30 to 60 millimeters, and often contains a high-density stainless steel or iron core for bottom weight. Once these pills sink to the bottom of a standard 1L container, they occupy more than 30% of the bottom spherical surface area, disrupting the symmetrical flow field and creating stagnant dead zones. The 2L and 4L systems offer an inner diameter of 120 to 150 mm and a vertical depth of nearly 300 mm, ensuring that even after the giant pellets settle, there is still a sufficient flow boundary layer. This effectively maintains the dynamic shear at the interface between laminar and turbulent flow, allowing for accurate assessment of the matrix's dissolution and diffusion dynamics.
Maintaining Sink Conditions for Extremely Poorly Soluble Anthelmintics: Most veterinary antiparasitic drugs (such as fenbendazole and oxfendazole) have saturation solubility in water of less than 1 μg/mL (< 1 ug/mL). A single tablet often contains hundreds to thousands of milligrams of drug. Even with the addition of 2% surfactant to 900 mL of medium, sink conditions cannot be achieved, and the release curve is prone to prematurely reaching a pseudo-saturation plateau at 20% to 40%. Using 4,000 mL of medium with a low concentration of physiological buffer can maintain the chemi-diffusion driving force while avoiding excessive solubilization interference from surfactants.
Hormonal growth promoters and long-acting veterinary implants: Implants such as progesterone and trenbolone acetate have a release period of up to several months, and large-volume media can maintain stable dissolution under long-term low-shear environments.
Large-area percutaneous drug delivery system for veterinary use: For deworming patches for large livestock with an area exceeding 50 cm2, a 2L/4L large-diameter clamping disc must be used to flatten and fix them.
III. Geometric Dimensions and Hydrodynamic Adaptability Analysis
To scale up a dissolution vessel from 1L to 2L or 4L, the stirring elements and container dimensions must be redesigned in accordance with the principle of dynamic similarity in fluid mechanics to ensure that the energy dissipation rate and flow shear stress can be reproduced and controlled.
[Geometric Dimension Design Standards Comparison]
Standard 1L dissolution system:
Nominal volume: 1,000 mL
Dissolution cup inner diameter (ID): 100 to 105 mm
Total height of the cup: 160 to 210 mm
Stirring paddle blade width: 74.5 +/- 0.5 mm
Stirring paddle height: 19.0 +/- 0.5 mm
Total length of the mixing shaft: approximately 350 mm
Drive shaft technology: Standard quick-release shaft
Blade base distance: 25 +/- 2 mm
2L large-volume dissolution system (such as Pharma Test PTWS 830-2):
Nominal volume: 2,000 mL
Dissolution cup inner diameter (ID): 120 to 125 mm
Total height of the cup: 220 to 250 mm
Stirring paddle blade width: 74.5 mm or proportionally increased to 90.0 mm
Stirring paddle height: 19.0 mm or proportionally increased to 25.0 mm
Total length of the mixing shaft: approximately 420 to 450 mm
Drive shaft technology: MonoShaft patented quick-release shaft / thickened anti-torsion shaft
Blade base distance: 25 +/- 2 mm
4L large-volume dissolution system (such as Logan UDT-818-4L):
Nominal volume: 4,000 mL
Dissolution cup inner diameter (ID): 145 to 150 mm
Total height of the cup: 280 to 310 mm
Stirring paddle blade width: 100.0 to 110.0 mm (for extra-large paddles)
Stirring paddle height: 30.0 to 35.0 mm
Total length of the mixing shaft: approximately 450 to 550 mm
Drive shaft technology: MonoShaft reinforced anti-resonance long shaft
Blade base distance: 25 +/- 2 mm
Key considerations in fluid dynamics
To prevent vertical fluid stratification (Anti-Stratification Effect): The liquid depth in a 4L cup increases from approximately 12 cm in a 1L cup to over 22 cm. If the standard small paddle is used in a 1L cup, the stirring kinetic energy is limited to a few centimeters from the bottom of the cup. The liquid layer above 2,000 mL will form a stagnant zone with near-zero flow velocity, preventing the dissolved and released drug from vertical convection. This results in drastic data fluctuations even with slight deviations in sampling height. Therefore, the 4L system must employ specially enlarged paddles or a double-layer propulsion structure with proven flow field characteristics.
Deflection & Resonance Control: The stirring shaft length is significantly extended to 45 to 55 cm. At 75 to 100 rpm, the centrifugal force and lateral fluid thrust on the long shaft increase significantly. The system must use high-rigidity AISI 316L medical-grade stainless steel and incorporate patented gapless quick-release joint technologies such as Pharma Test MonoShaft to eliminate resonance and non-physiological turbulence caused by stress concentration at the joints.
IV. Mechanical Qualification (MQ) Standards for 2L and 4L Systems
According to the US FDA guidelines for mechanical validation of dissolution testers and USP general specifications, large-volume systems, due to their large liquid loads and long drive arms, must maintain validation tolerances that are as stringent as the standard 1L.
Coaxial Geometric Centering: The maximum coaxial deviation between the center of the stirring shaft and the top and bottom of the inner wall of the 2L/4L cup is <= 2.0 mm (strict standard requirement <= 1.0 mm). Due to the large diameter and heavy weight of the large-volume cup, a dedicated three-point or four-point self-centering retainer must be used to firmly lock the cup lip and prevent slight displacement.
Stirring shaft wobble: Measured with a dial indicator rotating 360 degrees along the entire length of the long shaft (especially 1 cm above the paddles), the total indicated reading (TIR) must be maintained within <= 1.0 mm.
Verticality: Measured with a calibrated digital precision level, the verticality deviation of the stirring shaft and the inner wall of the dissolution cup relative to the water bath reference plate must be strictly controlled within the range of 90.0 degrees +/- 0.5 degrees.
Speed Accuracy & Load: Speed error must be maintained within +/- 4% of the set value (practical operation requires within +/- 1 rpm). When 6 to 8 4L cups are filled with the medium, the total liquid weight reaches 24 to 32 kg, and the swirling water resistance torque is 3 to 4 times that of conventional systems. The main drive mechanism must use a high-torque brushless DC motor (BLDC) or a closed-loop stepper system to ensure that slippage or loss of step does not occur under long-term heavy load operation.
Thermodynamic uniformity and temperature validation: The steady-state temperature of the medium at different depths within each dissolution vessel must reach 37.0 +/- 0.5°C. A standard 1,000W heater is insufficient to meet the circulation requirements of large water baths of 35 liters or more. An independent external high-lift circulation heating station of 1,500W to 2,000W must be configured, and multi-directional diffusing diffusers must be installed inside the water bath to eliminate dead zone temperature differences.
V. Integration of Automated Sampling, Media Preparation and In-situ Cleaning Systems
Large-volume dissolution tests involve extremely large batches of media (up to 24-32 L per batch) and heavy equipment. Relying on manual operation can easily lead to occupational safety and health (EHS) risks and human error. Modern laboratories must implement highly automated modules.
40L Portable Automated Media Preparation and Degassing System (e.g., Logan MDS-700 / Pharma Test PT-DDS4): An 8-tank, 4L test requires 32 liters of buffer solution per batch. Manual batch preparation using traditional vacuum bottles is time-consuming and labor-intensive. The automated system uses a 40-liter stainless steel vacuum tank, preheating online to 37.0 +/- 0.3°C while simultaneously using high-vacuum dynamic thin-film degassing to strictly reduce dissolved oxygen to below 6 ppm (meeting USP Toolkit requirements). The system, through a precision metering pump or servo dispensing gun, can accurately dispense each cup within 2 minutes, with a volumetric error of < +/- 0.8%.
Multi-channel extended automated sampling workstations (such as the Logan DLA series / Pharma Test EPE series): The sampling probe tip must be precisely positioned at the midpoint between the top of the agitator blade and the liquid surface, and at least 10 mm from the cup wall. The system is equipped with a stepper motor-driven dual-stage lifting sampling arm and a long-gauge probe, dynamically adjusting the depth according to the sampling time and residual liquid level. Combined with a high-precision syringe pump or valveless ceramic plunger pump, it automatically performs tubing flushing, sample dispensing to HPLC/UPLC sample vials, 0.45-micron filtration, and simultaneously replenishes an equal volume of isothermal fresh medium preheated to 37°C.
In-situ 360-degree high-pressure cleaning and vacuum waste removal (such as the Merel dissoWASH series): A single 4L glass cup filled with liquid weighs over 5.5 kg. Manual disassembly, handling, and tipping can easily cause slippage, breakage, cuts, or chemical burns. The in-situ cleaning probe is directly inserted into the 2L/4L cup fixed in the water tank. The 360-degree rotating high-pressure nozzle is activated to flush the inner wall and stirring element. Simultaneously, the bottom vacuum pump removes all waste liquid (residual amount < 0.1 mL). The next batch of tests can be carried out continuously without disassembling any glass cups.
VI. Conclusions and Technology Selection Guide
The 2L and 4L large-volume dissolution systems are no longer just "larger versions" of traditional dissolution apparatuses, but core scientific tools for evaluating the in vitro release of high-dose poorly soluble drugs (BCS II/IV), long-acting microsphere gels, large-area patches (Apparatus 5), and giant sustained-release pellets for animals.
When establishing a large-volume dissolution method, in addition to demonstrating the geometric similarity of the flow field and the multiple of the sink condition in the methodology validation report, the analysis team must implement the mechanical validation (MQ) procedure under heavy load (focusing on monitoring the long axis runout, geometric center coaxiality, and motor load speed stability), and cooperate with automated solution preparation, dynamic sampling, and in-situ cleaning modules to ensure that the in vitro release data has high reproducibility, discriminative power, and compliance with international regulations.
[Professional Consultation and Sample Testing Planning]
DS team possesses over 20 years of experience in mechanical structure validation, automated flow path integration, and international pharmacopoeia regulations, spanning both American and European OEMs. If your laboratory is evaluating the establishment of a large-volume dissolution system, special fixture prototyping, or automated solution preparation and cleaning solutions, please feel free to contact us:
■ Official website: www.dissolution.com.tw
■ Product Zone:
Logan dissolution tester series (UDT-818-8 / 12 / 2L / 4L configurations, DLA sampling workstation, MDS-700 automatic dissolution cart)
Pharma Test German dissolution analyzer series (PTWS 820D / PTWS 830 / PTWS1230-2L large-volume dedicated model, PT-DDS4 automatic solution preparation and degassing analyzer)
Merel in Slovenia - 360° in-situ dissolution cup automatic cleaning system (dissoWASH / dissoDOSE)
Professional consultation and online sample testing planning
Welcome to visit the DS website by clicking the link below, or fill out the online consultation form. Our professional technical consultants will plan a customized regulatory compliance and equipment selection solution for your laboratory.
Official website : www.dissolution.com.tw
Product Section : USP1/2/5/6& Media preparation & washing systems
Technical consultation hotline : 04-2241-1607